To assess the value of the Advanced Lung Cancer Inflammation Index in determining prognosis in patients with HFpEF, the researchers assessed patient data from the registry of Osaka’s Prospective Multicenter...
Recent research investigated the cardiovascular safety of nonsteroidal anti-inflammatory drugs (NSAIDs) and estimated the risk of hospital admission for heart failure with use of individual NSAIDs.
A recent study examined the effect of liraglutide, which has been shown to have cardioprotective effects, on outcomes in patients with heart failure and reduced left ventricular ejection fraction.
Noting that patients with heart failure are at high risk for hospital readmission in the first 30 days following HF hospitalization, study authors sought to determine if treatment with sacubitril/valsartan...
A recent scientific statement from the American Heart Association provides a thorough and accessible list of drugs that may cause or exacerbate heart failure to assist health care providers in improving the...
A recent study aimed to quantify rates of deaths prevented or postponed with angiotensin receptor neprilysin inhibition therapy for patients with heart failure.
The American College of Cardiology, American Heart Association, and the Heart Failure Society of America have updated their guidelines on treating heart failure.
